Advances in the prognostication and management of advanced MDS in children.
about
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans.Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesDefective proliferative potential of MSCs from pediatric myelodysplastic syndrome patients is associated with cell senescence.MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.Update on cytogenetic and molecular changes in myelodysplastic syndromes.Therapeutic approaches to haematological malignancies in adolescents and young adults.Understanding chronic neutropenia: life is short.Heterogeneity of GATA2-related myeloid neoplasms.Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantationTechniques for detecting chromosomal aberrations in myelodysplastic syndromesClinical utility of chromosomal microarray analysis in the diagnosis and management of monosomy 7 mosaicism.Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML.Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.[Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.An uncommon t(9;11)(p24;q22) with monoallelic loss of and genes in a child with myelodysplastic syndrome/acute myeloid leukemia who evolved from Fanconi anemia
P2860
Q33428604-417BEBB8-97A4-466F-B0F5-7D058C5D5CCCQ33617141-539E522F-DA92-42C5-ACB4-024B6408F1F7Q36266642-03FDC310-17CC-45B4-8359-BCC598FFD4C2Q36375313-20C65BD8-954F-4F14-92F9-0153FEF13546Q36862518-60E5D2D5-6ABD-490A-BBC8-00F38158FDCCQ37923939-3E7D265F-7D81-4FD9-AD7D-C27F6954E543Q38134399-1C13AB91-3240-41D1-B83B-063A98E4C7BEQ38604646-2A507114-303C-436C-B2CF-C7DBF3237369Q39393034-745A4C0D-AEA2-4317-A3D8-D6CE2151A8BEQ39474990-6D5A760C-32DB-46B2-AF01-869986225808Q41791233-A24C26E4-E771-44CE-8BEF-0FAFF152B6BCQ43072702-3B9567D2-5AE0-4685-A833-716C14AD701BQ43507348-5AE4D91E-8163-47F8-BD0D-56047CD11081Q43737380-177F865F-BCD0-4123-AC29-755FB0E89D19Q44325617-45759382-2724-48CA-91A9-F2655837012AQ51404366-B8922C8B-DDF7-4F4C-8DA8-41722BD0B778Q56526608-BEE5F277-1868-4650-87BB-E35DB4849ADE
P2860
Advances in the prognostication and management of advanced MDS in children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in the prognostication and management of advanced MDS in children.
@en
Advances in the prognostication and management of advanced MDS in children.
@nl
type
label
Advances in the prognostication and management of advanced MDS in children.
@en
Advances in the prognostication and management of advanced MDS in children.
@nl
prefLabel
Advances in the prognostication and management of advanced MDS in children.
@en
Advances in the prognostication and management of advanced MDS in children.
@nl
P2860
P1476
Advances in the prognostication and management of advanced MDS in children.
@en
P2093
Charlotte M Niemeyer
P2860
P304
P356
10.1111/J.1365-2141.2011.08724.X
P407
P50
P577
2011-05-09T00:00:00Z